| Size & multiples | |||
| Market Cap | $9.14B | Enterprise Value | $8.98B |
| P/E (TTM) | — | PEG (trailing) | — |
| P/S | 8.64× | P/FCF | — |
| EV/EBITDA | — | EV/EBIT | — |
| EV/Sales | 8.49× | EV/FCF | — |
| FCF Yield | −10.63% | Buyback Yield | 0.00% |
| Owner Earnings (TTM) | -$327.0M | Owner Earnings Yield | −3.58% |
| Shareholder Yield | — | ||
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 0.40 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 6.01% |
| After-tax Cost of Debt | — | WACC | — |
| ROIC | — | EVA Spread (ROIC−WACC) | — |
| EVA | — | ||
FCF sits 197% below owner earnings — spending above maintenance (growth capex) or absorbing working capital, so FCF understates the steady-state cash the business throws off.
Flows TTM (last 4 quarters) · EPS TTM -$2.07 · revenue TTM $1.06B · FCF TTM -$971.3M
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| FCF Yield | -3.5% | -7.8% | -34.7%–1.4% | 60 ↑strong |
| Net Margin | -40.4% | -21.2% | -325.3%–7.2% | 44 ↓weak |
| Operating Margin | -40.4% | -34.5% | -552.0%–8.0% | 48 ↓weak |
| ROE | -70.8% | -36.8% | -92.5%–4.5% | 32 ↓weak |
